American Well Co. (NYSE:AMWL) Short Interest Down 6.1% in May

American Well Co. (NYSE:AMWLGet Free Report) was the recipient of a significant decline in short interest in May. As of May 15th, there was short interest totalling 12,710,000 shares, a decline of 6.1% from the April 30th total of 13,530,000 shares. Based on an average daily trading volume, of 2,400,000 shares, the short-interest ratio is currently 5.3 days.

Analysts Set New Price Targets

AMWL has been the subject of a number of research reports. Needham & Company LLC reiterated a “hold” rating on shares of American Well in a research report on Thursday, May 2nd. Morgan Stanley reduced their price objective on American Well from $1.75 to $1.00 and set an “equal weight” rating for the company in a report on Monday, April 15th. Finally, UBS Group lowered their target price on American Well from $1.50 to $0.60 and set a “neutral” rating on the stock in a report on Thursday, May 23rd.

Read Our Latest Report on AMWL

American Well Price Performance

Shares of NYSE AMWL opened at $0.42 on Tuesday. The firm’s 50-day moving average is $0.57 and its two-hundred day moving average is $0.96. The company has a market capitalization of $125.58 million, a PE ratio of -0.34 and a beta of 1.12. American Well has a 12-month low of $0.39 and a 12-month high of $2.74.

American Well (NYSE:AMWLGet Free Report) last posted its earnings results on Wednesday, May 1st. The company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.07). The company had revenue of $59.52 million during the quarter, compared to analysts’ expectations of $61.10 million. American Well had a negative net margin of 137.32% and a negative return on equity of 46.76%. During the same period in the previous year, the company posted ($0.24) EPS. On average, analysts forecast that American Well will post -0.75 EPS for the current fiscal year.

Institutional Trading of American Well

Large investors have recently made changes to their positions in the stock. GSA Capital Partners LLP lifted its stake in shares of American Well by 75.5% during the third quarter. GSA Capital Partners LLP now owns 716,830 shares of the company’s stock valued at $839,000 after buying an additional 308,418 shares during the period. Sapient Capital LLC acquired a new stake in shares of American Well during the fourth quarter worth $247,000. Quadrature Capital Ltd purchased a new position in American Well during the third quarter worth about $36,000. Barclays PLC boosted its stake in American Well by 8.8% in the 3rd quarter. Barclays PLC now owns 173,359 shares of the company’s stock worth $203,000 after buying an additional 14,021 shares during the last quarter. Finally, Swiss National Bank grew its holdings in American Well by 2.3% in the 3rd quarter. Swiss National Bank now owns 463,200 shares of the company’s stock valued at $542,000 after buying an additional 10,500 shares during the period. Institutional investors and hedge funds own 56.05% of the company’s stock.

American Well Company Profile

(Get Free Report)

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.

Further Reading

Receive News & Ratings for American Well Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Well and related companies with MarketBeat.com's FREE daily email newsletter.